Publication:
Impact of 2022 AAP Neonatal Hyperbilirubinemia Guidelines in a Middle-Income Country: A Single-Center Study in Thailand

dc.contributor.authorVongbhavit K.
dc.contributor.authorRearkyai S.
dc.contributor.authorJanyoungsak P.
dc.contributor.authorPanburana J.
dc.contributor.correspondenceVongbhavit K.
dc.contributor.otherSrinakharinwirot University
dc.date.accessioned2025-12-06T19:00:02Z
dc.date.issued2025-01-01
dc.date.issuedBE2568-01-01
dc.identifier.citationNeonatology (2025) , 1-9
dc.identifier.doi10.1159/000547630
dc.identifier.eissn16617819
dc.identifier.issn16617800
dc.identifier.pmid40815110
dc.identifier.scopus2-s2.0-105023189725
dc.identifier.urihttps://hdl.handle.net/20.500.14740/54962
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.titleImpact of 2022 AAP Neonatal Hyperbilirubinemia Guidelines in a Middle-Income Country: A Single-Center Study in Thailand
dc.typeArticle
dspace.entity.typePublication
oaire.citation.endPage9
oaire.citation.startPage1
oaire.citation.titleNeonatology
oairecerif.author.affiliationFaculty of Medicine, Srinakharinwirot University
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105023189725&origin=inward

Files